[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100639905":3},{"organization":4,"outcomesModule":7,"designInfo":27,"detailedDescription":26,"studyPopulation":26,"armGroups":33,"interventions":40,"overallOfficials":26,"centralContacts":44,"locations":26,"responsibleParty":50,"collaborators":26,"id":52,"slug":26,"hasResults":53,"nctId":54,"briefTitle":55,"officialTitle":56,"acronym":26,"eligibilityCriteria":57,"healthyVolunteers":58,"sex":59,"minAge":60,"maxAge":26,"enrollmentInfo":61,"targetDuration":26,"studyType":64,"phases":65,"briefSummary":66,"conditions":67,"keywords":69,"overallStatus":71,"whyStopped":26,"lastUpdateSubmitDate":72,"lastUpdatePostDateStruct":73,"startDateStruct":76,"completionDateStruct":78,"leadSponsor":80,"locationsCount":26},{"fullName":5,"class":6},"Beijing Anzhen Hospital","OTHER",{"primaryOutcomes":8,"secondaryOutcomes":13,"otherOutcomes":26},[9],{"measure":10,"description":11,"timeFrame":12},"AF Detection Rate","The proportion of participants in whom atrial fibrillation is detected by the patch ECG recorder during the 7-day monitoring period.","7 days from device application",[14,18,22],{"measure":15,"description":16,"timeFrame":17},"Rate of newly diagnosed AF (previously undetected)","The proportion of participants in whom new, previously undiagnosed AF is identified through screening.","Time Frame: 7 days from device application",{"measure":19,"description":20,"timeFrame":21},"Treatment uptake rate","The proportion of participants with screen-detected AF who receive appropriate treatment (including anticoagulation, antiarrhythmic therapy, or other guideline-recommended interventions) within 6 months of detection.","6 months post-screening",{"measure":23,"description":24,"timeFrame":25},"Major adverse cardiovascular events (MACE)","Composite of all-cause death, ischemic stroke, and hospitalization for heart failure assessed during annual follow-up.","Annual follow-up over 10 years",null,{"allocation":28,"interventionModel":29,"interventionModelDescription":26,"primaryPurpose":30,"observationalModel":26,"timePerspective":26,"maskingInfo":31},"NA","SINGLE_GROUP","SCREENING",{"masking":32,"maskingDescription":26,"whoMasked":26},"NONE",[34],{"label":35,"type":36,"description":37,"interventionNames":38},"Single-lead patch ECG recorder","EXPERIMENTAL","All enrolled participants will wear a single-lead patch ECG recorder for 7 consecutive days. The device continuously records cardiac electrical activity, which is wirelessly transmitted to a central database for real-time analysis. AF episodes detected will be reviewed by the clinical team and communicated to the participant's primary care physician for further management.",[39],"Device: Single-lead patch ECG recorder",[41],{"type":42,"name":35,"description":37,"armGroupLabels":43,"otherNames":26},"DEVICE",[35],[45],{"name":46,"role":47,"phone":48,"phoneExt":26,"email":49},"Song Zuo, MD","CONTACT","+8618801427775","song_zuo@126.com",{"type":51,"investigatorFullName":26,"investigatorTitle":26,"investigatorAffiliation":26,"oldNameTitle":26,"oldOrganization":26},"SPONSOR","100639905",false,"NCT07627672","Effectiveness of Patch-Electrocardiogram Recorders in Screening for Atrial Fibrillation in Elderly People in the Chinese Community","Effectiveness of Patch-Electrocardiogram Recorders in Screening for Atrial Fibrillation in Elderly People in the Chinese Community: A Prospective Multicenter Study","Inclusion Criteria:\n\n* Age ≥60 years\n* No prior diagnosis of atrial fibrillation\n* Able to understand the study purpose and willing to provide written informed consent\n* No severe cardiac disease, acute illness, or contraindication to ECG monitoring\n* Able to wear the patch ECG device and comply with continuous monitoring requirements\n\nExclusion Criteria:\n\n* Severe cognitive impairment or inability to cooperate with follow-up assessments\n* Pregnant or breastfeeding women\n* Previously diagnosed with atrial fibrillation and already receiving treatment",true,"ALL","60 Years",{"count":62,"type":63},30000,"ESTIMATED","INTERVENTIONAL",[28],"This prospective, multicenter, single-arm study evaluates the effectiveness of a single-lead patch electrocardiogram (ECG) recorder in screening for atrial fibrillation (AF) among community-dwelling elderly individuals aged ≥60 years in China. Participants will undergo 7 days of continuous ECG monitoring, followed by annual follow-up for up to 10 years to assess long-term outcomes including stroke, heart failure, and death.",[68],"Atrial Fibrillation",[70],"Atrial fibrillation; AF screening; Patch ECG; Wearable ECG; Elderly; Community screening; China; FINDING-AF","NOT_YET_RECRUITING","2026-05-31",{"date":74,"type":75},"2026-06-04","ACTUAL",{"date":77,"type":63},"2026-09-01",{"date":79,"type":63},"2036-09-30",{"name":5,"class":6}]